In the COPD discovery set, we selected four key genes—MFSD10, GRK4, TET2, and HTT—for SMR and colocalization analyses within their respective tissues to strengthen the robustness of the results. The gene discussed is GRK4; the disease is chronic obstructive pulmonary disease.